Background Cervical cancer is the fourth most common cancer amongst women worldwide.
In the United States, its incidence and mortality have been declining due to the wide scale …

The COVID-19 pandemic has a major impact on a wide range of health outcomes.
Disruptions of elective health services related to cervical screening, management of …

Importance Uterine cancer incidence has been increasing, particularly rates of aggressive,
nonendometrioid subtypes, which are disproportionately higher among non-Hispanic Black …

Ovarian cancer is the most lethal gynecologic malignancy, characterized by a high death-to-
incidence ratio. Platinum-based chemotherapy is the mainstay of treatment for newly …

Background: In contrast with the decreasing incidence seen for most cancers, endometrial
cancer has been increasing in the United States. We examined whether the increasing …

Recent advances in molecular studies, especially genome-wide analyses, have revealed
the landscape of genomic alterations present in endometrial carcinomas, and have provided …

The Centers for Disease Control and Prevention recognized the need for educational
materials for clinicians on the prevention and early diagnosis of gynecologic cancers. The …

Background: Incidence and survival rates of nonserous epithelial ovarian cancer in
racial/ethnic minorities remain relatively unknown in the United States. We examined the …

Background Uterine corpus cancer is the most common invasive gynecologic cancer among
US women. Studies of endometrial cancers, which comprise approximately 90% of all …

Ovarian cancer (OVCA) is the second most common gynecological cancer and one of the
leading causes of cancer related mortality among women. Recent studies suggest that …